Groove Botanicals GRVE
OTC GRVE
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Groove Botanicals Inc. (GRVE) EBT (2010 - 2026)

Groove Botanicals (GRVE) posted EBT of -$35497.0 for Q1 2026, down 4.81% sequentially from -$33867.0 in Q4 2025, and down 12.94% YoY from -$40773.0 in Q1 2025.

Groove Botanicals Inc. (GRVE) EBT (2010 - 2026) Analysis & Trends

Groove Botanicals has reported EBT for 13 years, with the latest figure at -$35497.0 in Q1 2026.

  • Quarterly EBT fell 12.94% year-over-year to -$35497.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$139917.0 (down 6.94% YoY) and the FY2026 annual result came in at -$139917.0, down 6.94% from the prior year.
  • EBT fell to -$35497.0 in Q1 2026 per GRVE's latest filing, from -$33867.0 in the prior quarter.
  • Over five years, EBT peaked at -$29833.0 in Q3 2024 and troughed at -$126227.0 in Q2 2023.
  • A 5-year average of -$46451.1 and a median of -$36539.0 in 2024 frame the typical range for EBT.
  • The sharpest annual moves came in 2023 and 2024: EBT tumbled 39.08% in 2023, then surged 71.05% in 2024.
  • Over 5 years, EBT stood at -$41305.0 in 2022, then slumped by 39.08% to -$57446.0 in 2023, then soared by 42.5% to -$33031.0 in 2024, then fell by 2.53% to -$33867.0 in 2025, then dropped by 4.81% to -$35497.0 in 2026.
  • According to Business Quant data, EBT over the past three periods registered -$35497.0, -$33867.0, and -$32383.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -28,318.00
Mar 31, 2026 -35,497.00
Dec 31, 2025 -33,867.00
Sep 30, 2025 -32,383.00
Jun 30, 2025 -38,170.00
Mar 31, 2025 -31,430.00
Dec 31, 2024 -33,031.00
Sep 30, 2024 -29,833.00
Jun 30, 2024 -36,539.00
Mar 31, 2024 -59,613.00
Dec 31, 2023 -57,446.00
Sep 30, 2023 -30,045.00
Jun 30, 2023 -126,227.00
Mar 31, 2023 -62,149.00
Dec 31, 2022 -41,305.00
Sep 30, 2022 -49,232.00
Dec 31, 2017 -16,573.00
Sep 30, 2017 -32,503.00
Jun 30, 2017 -30,543.00
Mar 31, 2017 -89,902.00